NeoPhore Ltd

NeoPhore signs research collaboration with The Institute of Cancer Research, London

London, UK, 18 April 2023, - NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces that it has signed a strategic collaboration agreement with Professor Chris Lordís lab at The Institute of Cancer Research, London. The collaboration will use NeoPhore's proprietary small molecule inhibitors of DNA mismatch repair ('MMR') to investigate single agent activity...
3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT United Kingdom

+44 0 330 128 9990